Biomedical Seminar Series

“Tumor Resistance: A Mix of Cell Repopulation, Energy Reprogramming, and Escaping Immune Surveillance” will be presented by Jian Jian Li, M.D., Ph.D.,  Professor in the Department of Radiation Oncology at the University of California at Davis, School of Medicine. 

Dr. Li’s research interests include the study of the molecular mechanisms causing tumor resistance to radiation and chemotherapy. A tumor resistant signaling network regulated by the transcription factor NF?B and a group of proteins that translocate to the mitochondrion are being investigated in an array of human cancers including breast, lung, prostate and liver.

Additional projects are related to radiation-induced adaptive response in normal tissues and in the radiation-resistant cancer stem cells. The goal of these studies is to find therapeutic targets to enhance cancer cure rates by radiotherapy.

If you are interested in meeting with Dr. Miranti for a one-on-one meeting, please sign up here.

For questions, contact Breezy Tottenhoff.